Vinayak Singh

1.9k total citations
51 papers, 1.1k citations indexed

About

Vinayak Singh is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Vinayak Singh has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 27 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in Vinayak Singh's work include Tuberculosis Research and Epidemiology (32 papers), Biochemical and Molecular Research (14 papers) and Cancer therapeutics and mechanisms (13 papers). Vinayak Singh is often cited by papers focused on Tuberculosis Research and Epidemiology (32 papers), Biochemical and Molecular Research (14 papers) and Cancer therapeutics and mechanisms (13 papers). Vinayak Singh collaborates with scholars based in South Africa, India and United States. Vinayak Singh's co-authors include Kelly Chibale, Valerie Mizrahi, Kelly Chibale, Katharigatta N. Venugopala, Stanislav Huszár, Pran Kishore Deb, Pobitra Borah, Ranjana Srivastava, Digby F. Warner and Brahm S. Srivastava and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Accounts of Chemical Research.

In The Last Decade

Vinayak Singh

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinayak Singh South Africa 21 559 518 263 250 101 51 1.1k
David Barros Spain 19 458 0.8× 478 0.9× 198 0.8× 260 1.0× 112 1.1× 22 870
Vincent Delorme France 19 482 0.9× 452 0.9× 148 0.6× 300 1.2× 58 0.6× 32 1.0k
Sun‐Hee Kang South Korea 12 481 0.9× 518 1.0× 235 0.9× 311 1.2× 60 0.6× 24 972
Victoria Jones United States 16 501 0.9× 589 1.1× 221 0.8× 444 1.8× 50 0.5× 19 1.0k
Anna E. Grzegorzewicz United States 16 669 1.2× 751 1.4× 344 1.3× 529 2.1× 71 0.7× 32 1.3k
Nicolas Willand France 20 606 1.1× 411 0.8× 408 1.6× 193 0.8× 134 1.3× 58 1.2k
Marco Pieroni Italy 23 771 1.4× 493 1.0× 683 2.6× 332 1.3× 92 0.9× 58 1.6k
Gülçin Gülten United States 11 365 0.7× 398 0.8× 169 0.6× 196 0.8× 108 1.1× 14 699
Anthony Vocat Switzerland 14 669 1.2× 697 1.3× 309 1.2× 363 1.5× 96 1.0× 32 1.2k
Ill Young Lee South Korea 12 392 0.7× 454 0.9× 311 1.2× 323 1.3× 37 0.4× 18 938

Countries citing papers authored by Vinayak Singh

Since Specialization
Citations

This map shows the geographic impact of Vinayak Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinayak Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinayak Singh more than expected).

Fields of papers citing papers by Vinayak Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinayak Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinayak Singh. The network helps show where Vinayak Singh may publish in the future.

Co-authorship network of co-authors of Vinayak Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Vinayak Singh. A scholar is included among the top collaborators of Vinayak Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinayak Singh. Vinayak Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Sumit, et al.. (2024). Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans. ACS Infectious Diseases. 10(2). 251–269. 1 indexed citations
2.
Singh, Vinayak, et al.. (2024). Alternative therapeutics to control antimicrobial resistance: a general perspective. SHILAP Revista de lepidopterología. 4. 26 indexed citations
3.
Singh, Vinayak, Godwin Akpeko Dziwornu, & Kelly Chibale. (2023). The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics. Nature Reviews Chemistry. 7(5). 340–354. 12 indexed citations
4.
Kumar, Sumit, et al.. (2023). Recent developments of imidazo[1,2-a]pyridine analogues as antituberculosis agents. RSC Medicinal Chemistry. 14(4). 644–657. 36 indexed citations
5.
Singh, Vinayak, Deviprasad R. Gollapalli, Thomas R. Ioerger, et al.. (2022). A d-Phenylalanine-Benzoxazole Derivative Reveals the Role of the Essential Enzyme Rv3603c in the Pantothenate Biosynthetic Pathway of Mycobacterium tuberculosis. ACS Infectious Diseases. 8(2). 330–342. 4 indexed citations
6.
Singh, Vinayak, Elizabeth Kigondu, Pooja Agarwal, et al.. (2021). Developing Synergistic Drug Combinations To Restore Antibiotic Sensitivity in Drug-Resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 65(5). 20 indexed citations
7.
Huszár, Stanislav, Péter Baráth, Stanislav Kozmon, et al.. (2021). An ABC transporter Wzm–Wzt catalyzes translocation of lipid-linked galactan across the plasma membrane in mycobacteria. Proceedings of the National Academy of Sciences. 118(17). 6 indexed citations
8.
Borah, Pobitra, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.. (2021). Perspectives on RNA Vaccine Candidates for COVID-19. Frontiers in Molecular Biosciences. 8. 635245–635245. 40 indexed citations
9.
Huszár, Stanislav, Kelly Chibale, & Vinayak Singh. (2020). The quest for the holy grail: new antitubercular chemical entities, targets and strategies. Drug Discovery Today. 25(4). 772–780. 49 indexed citations
10.
Borah, Pobitra, Pran Kishore Deb, Katharigatta N. Venugopala, et al.. (2020). Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies. Current Topics in Medicinal Chemistry. 21(6). 547–570. 30 indexed citations
11.
Price, Neil P. J., et al.. (2019). Synergistic enhancement of beta-lactam antibiotics by modified tunicamycin analogs TunR1 and TunR2. The Journal of Antibiotics. 72(11). 807–815. 7 indexed citations
12.
Singh, Vinayak, A. Pacitto, Stefano Donini, et al.. (2019). Synthesis and Structure–Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH. European Journal of Medicinal Chemistry. 174. 309–329. 19 indexed citations
13.
Boshoff, Helena I., Vinayak Singh, Davide M. Ferraris, et al.. (2018). Expanding Benzoxazole-Based Inosine 5′-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents. Journal of Medicinal Chemistry. 61(11). 4739–4756. 28 indexed citations
14.
Trapero, Ana, A. Pacitto, Vinayak Singh, et al.. (2018). Fragment-Based Approach to Targeting Inosine-5′-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis. Journal of Medicinal Chemistry. 61(7). 2806–2822. 47 indexed citations
15.
Wood, Robin, Carl Morrow, Clifton E. Barry, et al.. (2016). Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC). PLoS ONE. 11(1). e0146658–e0146658. 39 indexed citations
16.
Majumdar, Gaurav, et al.. (2016). Genome-Wide Transposon Mutagenesis in Mycobacterium tuberculosis and Mycobacterium smegmatis. Methods in molecular biology. 1498. 321–335. 9 indexed citations
17.
Singh, Vinayak, Yap Boum, Victoria Katawera, et al.. (2016). Predictive modeling targets thymidylate synthase ThyX in Mycobacterium tuberculosis. Scientific Reports. 6(1). 27792–27792. 25 indexed citations
18.
Singh, Vinayak & Valerie Mizrahi. (2016). Identification and validation of novel drug targets in Mycobacterium tuberculosis. Drug Discovery Today. 22(3). 503–509. 58 indexed citations
19.
Singh, Vinayak, Raju Mukherjee, Joanna C. Evans, et al.. (2014). The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil. Chemistry & Biology. 22(1). 63–75. 71 indexed citations
20.
Singh, Vipul K., Vikas Srivastava, Vinayak Singh, et al.. (2011). Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice. Vaccine. 29(29-30). 4754–4760. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Barros Breakdown of academic impact, for papers by Vincent Delorme Breakdown of academic impact, for papers by Sun‐Hee Kang Breakdown of academic impact, for papers by Victoria Jones Breakdown of academic impact, for papers by Anna E. Grzegorzewicz Breakdown of academic impact, for papers by Nicolas Willand Breakdown of academic impact, for papers by Marco Pieroni Breakdown of academic impact, for papers by Gülçin Gülten Breakdown of academic impact, for papers by Anthony Vocat Breakdown of academic impact, for papers by Ill Young Lee
Rankless by CCL
2026